Liposomal 1,25 (OH)2 vitamin D3 compounds block proliferation and induce differentiation in myelomonocytic leukaemia cells

British Journal of Haematology

Volumn 98, Issue 1, 1997, Pages 186-194

  Frankenberger, Marion ^a   Hofmann, Barbara ^a   Emmerich, Bertold ^b   Nerl, Christoph ^c   Schwendener, Reto A ^d   Ziegler Heitbrock, H W Löms ^a,e  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Klinikum Schwabing   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e Institute for Immunology   (Germany)

Author keywords

AML; Differentiation; HL60; Liposome; Mono Mac 6

Indexed keywords

CALCITRIOL; LIPOSOME;

ADULT; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MALE; MYELOMONOCYTIC LEUKEMIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0030852269     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.1682984.x     Document Type: Article

References (46)

1. 3. Proceedings of the National Academy of Sciences of the United States of America, 78, 4990-4994.
2. Bangham, A.D., Standsh, M.M. & Watkins, J.C. (1965) Diffusion of univalent ions across the lamelae of swollen phospliolipids. Journal of Molecular Biology, 13, 238-252.
3. 3 slimulates expression and translocation of protein kinase Cα and Cδ via a nongenomic mechanism and rapidly induces phosphorylation of a 3 3-kDa protein in acute promyelocytic NB4 cells. Journal of Biological Chemistry, 271, 16090-16096.
4. 3 inhibits antigen-induced T cell activation. Journal of Immunology, 133, 1748-1754.
5. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochemical Pharmacology, 42, 1569-1575.
6. Brenner, D.E. (1989) Liposomal encapsulation: making old and new-drugs do new tricks. Journal of the National Cancer Institute, 81, 1436-1438.
7. Collins, S.J., Gallo, R.C. & Callagher, R.E. (1977) Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature, 270, 547.
8. Dodd, R.C., Cohen, M.S., Newman, S.L., & Gray, T.K. (1983) Vitamin D metabolites change the phenotype of monoblastic U937 cells. Proceedings of the National Academy of Sciences of the United States of America, 80, 7538-7541.
9. Drach, J., Lopez-Berestein, G., McQueen, T., Andreeff, M. & Mehta, K. (1993) Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid. Cancer Researeh, 53, 2100-2104.
10. 3. an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood, 84, 1960-1967.
11. 3H]muramyl tripeptide phosphatidyl-ethanolamine in mice. Journal of Immunology, 135, 1372-1377.
12. Fraser, D.R. (1995) Vitamin D. Lancet. 345, 104-107.
13. Gangadharam, P.R.J., Perumal, V.K., Kesavalu, L., Debs, R.J., Goldstein, J. & Duzgunes, N. (1989) Comparative activities of free and liposome encapsulated amikacin against Mycobacterium avium complex (MAC). Liposomes in the Therapy of Infectious Diseuses and Cancer (ed. by G. Lopez-Berestein and I. J. Fidler). pp. 177-190. Alan R. Liss, New York.
14. Gregoriadis, G. (1995) Engineering liposomes for drug delivery: progress and problems. Trends in Biotechnology, 13, 527-537.
15. Griflin, J.D., Ritz, J., Nadler, L.M. & Schlossman, S.F. (1981) Expression of myeloid differentiation antigens on normal and malignant myeloid cells. Journal of Clinical Investigation, 68, 932-941.
16. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proceedings of the National Academy of Scienees of the United States of America, 80, 201-204.
17. Huang, M., Ye, Y., Chen, S., Chai, J., Lu, J.-X., Zhoa, L., Gu, L. & Wang, Z. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
18. Kelsey, S.M., Newland, A.C., Cunningham, J., Makin, H.L.J., Coldwell, R.D., Mills, M.J. & Grant, I.R. (1992) Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes. Lancet, 340, 316-317.
19. Kleinermann, E.S., Murray, J.L., Snyder, J.S., Cunningham, J.E. & Fidler, I.J. (1989) Activation of tumoricidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidyl-ethanolamine. Cancer Research, 45, 4665-4670.
20. Koeffler, H.P. (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications, Blood, 62, 709-721.
21. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treatment Reports, 69, 1399-1406.
22. 3 on cytokine-induced thymocyte proliferation. Cellular Immunology, 96, 455-461.
23. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes and Development. 10, 142-153.
24. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. Journal of Cell Biology, 98, 391-398.
25. Mellibovsky, L., Diez, A., Aubia, J., Nogues, X., Pérez-Vila, E., Serrano, S. & Recker, R.R. (1993) Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia. British Journal of Haematology, 85, 811-812.
26. Minowada, J., Ohnuma, T. & Moore, G.E. (1972) Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. Journal of the National Cancer Institute, 49, 891-895.
27. 3 induces differentiation of human myeloid leukemia cells. Biochemical and Biophysical Research Communications, 102, 937-943.
28. Munker, R., Kobayashi, T., Elstner, E., Norman, A.W., Uskokovic, M., Zhang, W., Andreeff, M. & Koeffler, H.P. (1996) A new series of vitamin D analogs is highly active for clonal inhibition. differentiation, and induction of WAF1 in myeloid leukemia. Blood, 88, 2201-2209.
29. Munker, R., Norman, A. & Koeffler, H.P. (1986) Vitamin D compounds: effect of clonal proliferation and differentiation of human myeloid cells. Journal of Clinical Investigation, 78, 424-430.
30. 3 and phorbol-12-myristate-13-acetate. Cancer Research, 45, 4989-4996.
31. 3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. Journal of Biological Chemistry, 269, 23750-23756.
32. 3 induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 promyelocytic leukemia cell line. Molecular Immunology, 22, 567-572.
33. Sachs, L. (1978) Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature, 274, 535-539.
34. Sone, T., Kerner, S. & Pike, J.W. (1991) Vitamin D receptor interaction with specific DNA. Journal of Biological Chemistry, 266, 23296-23305.
35. Sundström, C. & Nilsson, K. (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). International Journal of Cancer, 17, 565-577.
36. Tanaka, H., Abe, E., Miyaura, C., Kuribayashi, T., Konno, K., Nishii, Y. & Suda, T. (1982) 1α,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochemical Journal, 204, 713-719.
37. 3. Cancer Research. 47, 2236-2242.
38. Van Rooijen, N. (1989) The liposome-mediated macrophage 'suicide' technique. Journal of Immunological Methods, 124, 1-6.
39. Vitols, S., Angelin, B., Ericsson, S., Gahrton, G., Juliusson, G., Masquelier, M., Paul, C., Peterson, C., Rudling, M., Söderberg-Reid, K. & Tidefelt, U. (1990) Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proceeding of the National Academy of Sciences of the United States of America, 87, 2598-2602.
40. 3 in HL60 cells. Cancer Research, 56, 264-267.
41. Warrell, R.P., de Thé, H., Wang, Z.-Y. & Degos, L. (1993) Acute promyelocytic leukemia. New England Journal of Medicine, 329, 177-189.
42. 3. Blood, 70, 994-1002.
43. Zhou, J.-Y., Norman, A.W., Lübbert, M., Collins, E.D., Uskokovic, M.R. & Koeffler, H.P. (1989) Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization. Blood, 74, 82-93.
44. Ziegler-Heitbrock, H.W.L & Burger, R. (1987) Rapid removal of mycoplasma from cell lines mediated by a direct effect of complement. Experimental Cell Research, 173, 388-394.
45. Ziegler-Heitbrock, H.W.L., Thiel, E., Fütterer, A., Herzog, V., Wirtz, A. & Riethmüller, G. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. International Journal of Cancer, 41, 456-461.
46. Ziegler-Heitbrock, H.W.L. & Ulevitch, R.J. (1993) CD14: cell surface receptor and differentiation marker. Immunology Today, 14, 121-125.